THURSDAY, Nov. 20, 2025 (HealthDay News) -- For adults with venous thromboembolism (VTE), continuing oral anticoagulants (OAC) after initial anticoagulation of
Continuing Oral Anticoagulants After ≥90 Days Tied to Lower Risk for Recurrent VTE
HealthDay2 hrs ago
133


KTRE 9 News
Associated Press US and World News Video
WHAS 11
CBS News
Missoula Current
Reuters US Domestic
Arizona Daily Sun
AlterNet
Raw Story